Duan Peng-Fei, Ni Cai-Fang
Department of Interventional Radiology, The First Affiliated Hospital of Soo Chow University, Suzhou, China.
Department of Interventional Radiology, The First Affiliated Hospital of Soo Chow University, Suzhou, China.
J Formos Med Assoc. 2016 Aug;115(8):652-7. doi: 10.1016/j.jfma.2015.07.001. Epub 2015 Jul 27.
BACKGROUND/PURPOSE: To investigate the feasibility, effectiveness, and complications of catheter-directed thrombolysis (CDT) using three different approaches for acute lower-extremity deep venous thrombosis (DVT).
A total of 106 patients with acute DVT were enrolled in this study. Forty-one patients received CDT through the small saphenous vein (Group A), 35 through the great saphenous vein (Group B), and 30 through the popliteal vein (Group C). Iliac vein balloon dilation and stenting was performed in 65 cases.
The vascular approach route was not statistically related to limb edema reduction rates (Groups A, B, and C: 82.3 ± 7.6% vs. 81.6 ± 6.0% vs. 83.9 ± 6.1%), nor to thrombolysis rates (63.5 ± 7.7% vs. 66.9 ± 8.4% vs. 66.1 ± 2.7%). The procedure was significantly shorter for Groups B and C. No significant difference was found between Groups B and C. Most complications occurred in Group A. The complication rate in Group B was the lowest. Eighty-eight patients were followed up for 7-24 months. Of these, 78 were pain-free and without limb edema; six showed rethrombosis.
CDT is an effective method to manage acute DVT. Of the three routes tested, the small saphenous vein route was associated with more frequent complications. Great saphenous vein catheterization was more effective because of its lower complication rate.
背景/目的:探讨采用三种不同方法对急性下肢深静脉血栓形成(DVT)进行导管直接溶栓(CDT)的可行性、有效性及并发症。
本研究共纳入106例急性DVT患者。41例患者经小隐静脉接受CDT(A组),35例经大隐静脉(B组),30例经腘静脉(C组)。65例患者行髂静脉球囊扩张及支架置入术。
血管入路途径与肢体水肿减轻率(A组、B组和C组:82.3±7.6% 对 81.6±6.0% 对 83.9±6.1%)及溶栓率(63.5±7.7% 对 66.9±8.4% 对 66.1±2.7%)无统计学关联。B组和C组的操作时间明显更短。B组和C组之间未发现显著差异。大多数并发症发生在A组。B组的并发症发生率最低。88例患者接受了7至24个月的随访。其中,78例无疼痛且无肢体水肿;6例出现再血栓形成。
CDT是治疗急性DVT的有效方法。在所测试的三种途径中,小隐静脉途径并发症更常见。大隐静脉置管更有效,因其并发症发生率较低。